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SUMMARY (VII)   
  
 
THE RELATIONSHIP BETWEEN SERUM LEVEL OF CYSTATĐN C AND DIASTOLIC 
DYSFUNCTION/ ENDOTHELIAL DYSFUNCTION AMONG PATIENTS WITH 
DIABETES MELLITUS 
 
 
Introduction:  
The prevalance of diabetes mellitus has been increasing dramatically during the last 
two decades. Genetic, enviromental and life style factors have been shown to participitate in 
the etiopathogenesis of this disease. It is characterized with hyperglisemia and may lead to 
microvascular and macrovascular complications. Cardiovascular diseases, neuropathy, 
retinopathy and diabetic nephropathy are among the most important complications. 
Atherosclerosis and related diseases are the second and first cause of death among the 
population with less and more than 45 years of age worldwide, respectively. It is the most 
important cause of morbidity among all ages of population and its incidence is increasing 
dramatically. Therefore, many authors attempt to develop new methods in order to diagnose 
aterosclerosis before development of organ involvement and determine the prevalance of 
aterosclerotic disease. 
The most important changes observed during the early subclinical period of 
aterosclerosis include endotelial dysfunction throughout all arterial bed and increase in 
intimal-medial thickness. Endothelial dysfunction and increase of intimal-medial thickness 
may be determined by using simple, inexpensive and non-invasive methods. So, therapeutic 
modalities can be performed before atherosclerosis becomes more diffuse. Endothelial 
dysfunction preceedes the atherosclerotic involvement on the coronary vascular bed. It also 
plays an important role in the atherosclerosis of epicardial coronary arteries. However, 
making the diagnosis of endothelial dysfunction is both difficult and requires invasive 
methods. Since the endothelial dysfunction may lead to systemic symptoms, non-invasive 
methods  imaging peripheral arteries may provide accurate information about endothelial 
dysfunciton. Brachial artery is ideal for evaluation of endothelial dysfunction since it is easily 
found on the antecubital region. This advantage leads us to diagnose possible endothelial 
dysfunction throughout coronary vascular bed by using indirect methods. 
Measurement of mitral diastolic flow and pulmonary venous flow via convantional 
Doppler echocardiography in order to evaluate diastolic left ventricular functions provides 
important data. However, since many factors (heart rate, pre-load, after-load, valvular failure, 
position of sample volume) may change the haemodynamics of mitral flow echocardiographic 
methods have recently been utilized for evaluation of diastolic dysfunction. Tissue Doppler 
Imaging (TDI) has recently been increasingly used for determination of left ventricular 
diastolic functions and regional systolic-diastolic functions of myocardium can be evaluated 
by using TDI. The rate of early diastolic wave (Em or E’) on the myocardium next to mitral 
annulus observed via tissue doppler imaging has been demonstrated to be a useful parameter 
for evaluation of LV diastolic functions.  
Cystatin C is a molecule composed of 122 aminoacides and has a molecular weight of 
13 kDa. It is a cystein protease inhibitor and involves a non-glycolized polypeptide. It is 
synthesized by all cells with nuclei. It is produced in a constant rate which is not affected by 
other factors such as immunological and inflammatory processes or body muscular mass. It is 
easily filtrated from glomerules due to the low molecular weight and non-acidic pH and its 
serum levels are stable. Cystatin C is a member of the cystatin superfamily in which all 
components are cystein protease inhibitors. 
 
In this study we planned to investigate the relationship between serum Cystatin C 
levels, and endothelial and diastolic dysfunction among the Type 2 diabetic patients who had 
normal serum albumin levels in the lack of microalbuminuria and coronary artery disease. 
 
Materials and Methods:  
Forty patients and 10 control subjects who admitted to the outpatient clinics of Adnan 
Menderes University Medical Faculty Department of Cardiology between January and June 
2008 and had the diagnosis of type 2 diabetes mellitus have been included in our study. All 
the patients and controls have signed an informed consent form. The included patients had the 
diagnosis of type 2 diabetes mellitus with history, physical examination and laboratory 
results; were taking antidiabetic medical therapy; more than 30 years of age; not taking 
systemic glucocorticoid therapy; had no hepatic failure, malignancy or pregnancy. Patients 
who had previously undergone coronary revascularization, carotis surgery or expreinced 
cerebrovascular disease have been excluded. 
              10 cc venous blood was obtained from each patient after 12 hours of fasting for 
determination of fasting plasma glucose level, Cystatin C level, lipid parameters, blood urea 
nitrogen and creatinin levels. Microalbumin level in the 24 hours of urine has also been 
measured. 
Transthorasic echocardiography was performed at all patients for evaluation of cardiac 
functions. Flow-induced vasodilatation test was performed in order to evaluate the endothelial 
dysfunciton via doppler ultrasoundography from bracihal artery.  
Results:  
This study was performed among 50 subjects (age range: 36 and 77 years) who 
presented to outpatient clinics of Cardiology Department of Adnan Menderes University 
Medical Faculty between January and June 2008. The mean age of the patients was 
52,48±8,77 years (mean±SD). 32 females (64%) and 18 males (36%) were included.  
Diastolic dysfunction was observed at 23 (46%) patients. Endothelial dysfunction was 
present at 13 (26%) patients.  Cystatin C levels were significantly higher at the patients 
compared with control subjects (p<0,001). 
Cystatin C levels were significantly higher among patients with endothelial 
dysfunction (p<0,002).  
Cystatin C levels of the patients with both diastolic and endothelial dysfunction were 
significantly higher than the other patients (p<0,004). 
 The ROC analysis performed to determine the cut-off value of Cystatin C levels 
according to endothelial dysfunction among study population revealed 1834 as the cutoff 
point, although not ideal at all. The sensitivity, specificity, positive and negative predictive 
value at this point were 91,67%, 78,57%, 64,71% and 95,65%, respectively. The area under 
the ROC curve was found to be 0,893.   
 
Comment:  
Evaluation of diastolic dysfunction by using echocardiography and endothelial 
dysfunction by using flow-induced vasodilatation test from brachial artery are both early 
findings of coronary artery diasease and atherosclerosis amnog type 2 diabetic patients. 
Significantly higher serum levels of Cystatin C among patients with endothelial dysfunction 
suggest that Cystatin C may serve as a predictive marker, as well as hsCRP, for future 
development of coronary artery disease and this study -to our knowledge- is the first trial 
investigating the relationship between endothelial dysfunction and serum Cystatin C levels. 
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